Given Douglas B
- SEC CIK
- 0001156207
No open-market purchases or sales filed in the past year.
Current role at each company
- ARWR Arrowhead Pharmaceuticals, Inc.Directoras of Dec 18, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Given Douglas B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2024 (view filing) | Dec 16-17 | 2 days | Given Douglas BDirector | SSale | −5.55K | $21.91 | −$121.6K | −4.3%124.2K after | 2 lots10b5-1 |
| Jan 16, 2024 (view filing) | Jan 11 | 5 days | Given Douglas BDirector | SSale | −2.91K | $38.06 | −$110.8K | −2.2%129.7K after | 2 lots10b5-1 |
| May 8, 2023 (view filing) | May 5 | 3 days | Given Douglas BDirector | SSale | −6.50K | $40.90 | −$265.9K | −5.2%117.6K after | |
| Mar 1, 2023 (view filing) | Feb 27 | 2 days | Given Douglas BDirector | SSale | −875 | $32.62 | −$28.5K | −6.3%13.0K after | |
| Dec 29, 2021 (view filing) | Dec 28 | 1 day | Given Douglas BDirector | PPurchase | +655 | $66.37 | +$43.5K | +0.6%109.9K after | |
| Sep 10, 2021 (view filing) | Sep 9 | 1 day | Given Douglas BDirector | SSale | −5.00K | $65.24 | −$326.2K | −4.4%109.9K after |